ASX - By Stock
|
ASN |
Re:
Ann: Opportunity to Develop Critical Minerals at Mary Spring
|
|
Ravagestone
|
35 |
12K |
4 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
35
|
12K
|
4
|
|
ASX - By Stock
|
MEM |
Re:
tax loss selling coming
|
|
Ravagestone
|
21 |
6.0K |
0 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
21
|
6.0K
|
0
|
|
ASX - By Stock
|
MEM |
Re:
tax loss selling coming
|
|
Ravagestone
|
21 |
6.0K |
2 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
21
|
6.0K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Ravagestone
|
533 |
263K |
11 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
533
|
263K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
Ravagestone
|
3.2K |
1.2M |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
3.2K
|
1.2M
|
3
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Ravagestone
|
13 |
4.3K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
13
|
4.3K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Ann: March 2024 Quarterly Update and Appendix 4C
|
|
Ravagestone
|
25 |
12K |
8 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
25
|
12K
|
8
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Ravagestone
|
13 |
4.3K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
13
|
4.3K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Ann: March 2024 Quarterly Update and Appendix 4C
|
|
Ravagestone
|
25 |
12K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
25
|
12K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ann: March 2024 Quarterly Update and Appendix 4C
|
|
Ravagestone
|
25 |
12K |
16 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
25
|
12K
|
16
|
|
ASX - By Stock
|
PTX |
Re:
Ann: March 2024 Quarterly Update and Appendix 4C
|
|
Ravagestone
|
25 |
12K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
25
|
12K
|
6
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Ravagestone
|
13 |
4.3K |
0 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
13
|
4.3K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Blocking agent
|
|
Ravagestone
|
11 |
5.3K |
7 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
11
|
5.3K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Blocking agent
|
|
Ravagestone
|
11 |
5.3K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
11
|
5.3K
|
4
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Ravagestone
|
533 |
263K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
533
|
263K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Ravagestone
|
533 |
263K |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
533
|
263K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Ravagestone
|
533 |
263K |
11 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
533
|
263K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Notification of cessation of securities - PAB
|
|
Ravagestone
|
21 |
5.3K |
3 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
21
|
5.3K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Ravagestone
|
533 |
263K |
8 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
533
|
263K
|
8
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Ravagestone
|
19 |
6.0K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
19
|
6.0K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Data to be presented at leading brain cancer conference
|
|
Ravagestone
|
6 |
2.0K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
6
|
2.0K
|
0
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Investor Presentation Sept 23
|
|
Ravagestone
|
50 |
14K |
1 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
50
|
14K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Ravagestone
|
533 |
263K |
7 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
533
|
263K
|
7
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4E and 2023 Annual Report
|
|
Ravagestone
|
21 |
10K |
1 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
21
|
10K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
PTX - Banter and General Comments
|
|
Ravagestone
|
159 |
56K |
3 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
159
|
56K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Ravagestone
|
533 |
263K |
2 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
533
|
263K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ann: June 2023 Quarterly Update and Appendix 4C
|
|
Ravagestone
|
45 |
18K |
15 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
45
|
18K
|
15
|
|
ASX - By Stock
|
MEM |
Re:
Ann: New Patents granted for Felix System
|
|
Ravagestone
|
13 |
5.3K |
1 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
13
|
5.3K
|
1
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Rights Issue Closure and Shortfall Notification
|
|
Ravagestone
|
10 |
5.6K |
0 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
10
|
5.6K
|
0
|
|
ASX - By Stock
|
MEM |
Re:
Ann: New Patents granted for Felix System
|
|
Ravagestone
|
13 |
5.3K |
1 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
13
|
5.3K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
Ravagestone
|
348 |
132K |
0 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
348
|
132K
|
0
|
|
ASX - By Stock
|
MEM |
Re:
Ann: New Patents granted for Felix System
|
|
Ravagestone
|
13 |
5.3K |
1 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
13
|
5.3K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
One year from now
|
|
Ravagestone
|
28 |
15K |
11 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
28
|
15K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
Ravagestone
|
1.6K |
676K |
3 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
1.6K
|
676K
|
3
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Paradox Lithium Plant Front End Engineering & Design Study
|
|
Ravagestone
|
167 |
49K |
3 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
167
|
49K
|
3
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Paradox Lithium Plant Front End Engineering & Design Study
|
|
Ravagestone
|
167 |
49K |
13 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
167
|
49K
|
13
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Paradox Lithium Plant Front End Engineering & Design Study
|
|
Ravagestone
|
167 |
49K |
1 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
167
|
49K
|
1
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
Ravagestone
|
22K |
6.7M |
8 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
22K
|
6.7M
|
8
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
Ravagestone
|
22K |
6.7M |
1 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
22K
|
6.7M
|
1
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
Ravagestone
|
22K |
6.7M |
4 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
22K
|
6.7M
|
4
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Two PTX abstracts accepted at prestigious ISCT conference
|
|
Ravagestone
|
34 |
16K |
2 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
34
|
16K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
Ravagestone
|
3.2K |
1.2M |
1 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
3.2K
|
1.2M
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2023
|
|
Ravagestone
|
102 |
37K |
3 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
102
|
37K
|
3
|
|
ASX - By Stock
|
ASN |
Re:
ASN Chart
|
|
Ravagestone
|
10K |
3.5M |
2 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
10K
|
3.5M
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Updated guidance for PAT-DX1 phase 1 clinical study
|
|
Ravagestone
|
125 |
48K |
5 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
125
|
48K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Updated guidance for PAT-DX1 phase 1 clinical study
|
|
Ravagestone
|
125 |
48K |
4 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
125
|
48K
|
4
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
Ravagestone
|
1.6K |
676K |
3 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
1.6K
|
676K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Continued promising results in PTX-100 TCL trial
|
|
Ravagestone
|
60 |
25K |
3 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
60
|
25K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Continued promising results in PTX-100 TCL trial
|
|
Ravagestone
|
60 |
25K |
18 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
60
|
25K
|
18
|
|
ASX - By Stock
|
PTX |
Re:
Ann: FDA grants broader orphan drug status to PTX100 for TCLs
|
|
Ravagestone
|
45 |
24K |
16 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
45
|
24K
|
16
|
|